SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)
CVM 6.995+5.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alys Hall who wrote (2221)11/17/1998 8:32:00 AM
From: fmrick  Read Replies (1) of 2836
 
Alys-

I think it is a lot of conjecture. As the last post points out it now looks like it is not us. But remember, Multikine has IL-2 and is also in testing like this. In fact the data should be out soon on that trial. The press release dated 6-3-97 outlines the start and the goals. If you read it you can see where some might have thought it may have been us. But I don't think it matters. IL-2 is a very funny drug. Very toxic in large doses. Multikine is different. One of the most interesting tings I have read about Multikine is,in some areas where it has been tested, it has worked better in smaller doses. Go figure. So if NIH is looking at IL-2 products, Multikine may be in play. And we know it is safe and non-toxic.

I don't think that is what is driving us. I think somebody knows what is up, but they are just not saying. I just hope the company does not let this chance go by without pushing whatever IS out there.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext